IL-21 R

IL-21 R

IL-21 R 詳細

Molecule Name
Interleukin 21 Receptor
分子の別称
IL21R,CD360,NILR
Drug Development Progress
治験薬の数2
市販薬剤の数0
研究&開発段階Phase 1 Clinical
ターゲットの別称
UNQ3121/PRO10273,Interleukin-21 receptor,IL21R,IL-21R,Interleukin 21 Receptor,Novel Interleukin Receptor,IL-21 Receptor,NILR,CD360 Antigen,CD360,IMD56,Receptors, Interleukin-21
バックグランド
Interleukin-21 receptor (IL21R) is also known as CD antigen CD360, Novel interleukin receptor (NILR), is a receptor for interleukin-21 and belongs to the type I cytokine receptor family or type 4 subfamily. IL21R contains two fibronectin type-III domains. IL21R is selectively expressed in lymphoid tissues and most highly expressed in thymus and spleen. IL21R transduces the growth promoting signal of IL21, and is important for the proliferation and differentiation of T cells, B cells, and natural killer (NK) cells.

IL-21 R 製品リスト

Species
  • Human(3)
  • Mouse(2)
  • Cynomolgus(1)
Tag
  • Fc Tag(3)
  • Fc Tag & Avi Tag(1)
  • His Tag(1)
  • His Tag & Avi Tag(1)
Host
  • HEK293(6)
Conjugate
  • Unconjugated(4)
  • Biotin-labeled(2)
Grade
  • RUO(6)
Low Endotoxin
  • Yes(1)
  • No(5)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
IL-21 R
Human IL-21 R Protein, His Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$300.00

200ug
IL-21 R
Mouse IL-21 R Protein, Fc Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE
ELISA

$270.00

100ug
IL-21 R
HOTAvitag
ILR-H82F7
Biotinylated Human IL-21 R Protein, Fc,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
IL-21 R
Human IL-21 R Protein, Fc Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPR

$320.00

200ug
IL-21 R
HOTAvitag
ILR-M82E3
Biotinylated Mouse IL-21 R Protein, His,Avitag™
Mouse
HEK293
SDS-PAGE
ELISA

$360.00

25ug
IL-21 R
Cynomolgus IL-21 R Protein, Fc Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISASPR

$270.00

100ug
You Have Viewed 1-6 Of 6 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
JS-014Exenokine-21; JS-014; AWT-008Phase 1 ClinicalAnwita Biosciences Inc
Carcinoma, Hepatocellular; Lymphoma; Neoplasms; Solid tumours
詳細
LatikafuspAMG-256Phase 1 ClinicalAmgen Inc
Solid tumours
詳細
Customer Reviews